Does Stringent Restrictive Annuloplasty for Functional Mitral Regurgitation Cause Functional Mitral Stenosis and Pulmonary Hypertension?
Satoshi Kainuma(National Cerebral and Cardiovascular Center), Yoshiki Sawa(Osaka Police Hospital), Kazuhiro Taniguchi(Hyogo Medical University), Yasuhiro Shudo(Stanford Health Care), Shigeru Miyagawa(The University of Osaka), Taichi Sakaguchi(Hyogo University), Takafumi Masai(Sakurabashi Watanabe Hospital), Takashi Daimon(Hyogo Medical University), Masami Nishino(Saga University), Shin‐ichi Fujita(Central Research Institute of Electric Power Industry), Koji Takeda(NewYork–Presbyterian Hospital), Toshihiro Funatsu(Hyogo Medical University), Haruhiko Kondoh(Hyogo Medical University)
Cited by 62
Related Papers
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab
|Science Translational Medicine|2011|670
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
Left Ventricular Unloading During Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock
|Journal of the American College of Cardiology|2019|398
Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2008|365